订阅小程序
旧版功能

AFNT-211: A Phase 1 Study of Autologous CD4+ and CD8+ T Cells Engineered to Express a High Avidity HLA-A*11:01-restricted, KRAS G12V-specific, Transgenic TCR, a CD8α/β Coreceptor, and a FAS41BB Switch Receptor in Patients with Advanced/metastatic Solid Tumors.

Scott A. Mitchell, Binaish Khan,Francis Payumo,E. Gabriela Chiorean,Zhubin Gahvari,J. Randolph Hecht,Michael E. Hurwitz,Rom S. Leidner,Heinz‐Josef Lenz,Meredith S. Pelster,Salman R. Punekar,Adam J. Schoenfeld,Dan Zhao,Markus Vallaster,Dirk Nagorsen

Journal of Clinical Oncology（2024）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要